Back
36
17
Day Range
$5.21
$5.22
52-Week Range
$3.91
$5.22
Volume
200
50D / 200D Avg
$4.40
/
$4.41
Prev Close
$5.08
Quick Summary
Price History
Financial Trends
Peer Comparison
vs Healthcare sector median (633 peers)
| Metric | Stock | Sector Median |
|---|---|---|
| P/E | -95.1 | 0.2 |
| P/B | 0.7 | 2.9 |
| ROE % | -0.7 | 3.7 |
| Net Margin % | -1.2 | 3.9 |
| Rev Growth 5Y % | 16.6 | 10.0 |
| D/E | 0.1 | 0.2 |
Dividend History
Yield
0.00%
Payout Ratio
0.00%
Growth (3Y)
N/A
Growth (5Y)
N/A
No dividend history available.
Key Takeaways
Revenue grew 16.58% annually over 5 years — strong growth
Earnings declined -223.95% over the past year
Debt/Equity of 0.10 — conservative balance sheet
Generating 68.34M in free cash flow
PEG of 0.50 suggests growth is underpriced
Revenue growth is accelerating — 1Y growth exceeds 5Y average by 4.54%
Growth
Revenue Growth (5Y)
16.58%
Revenue (1Y)21.12%
Earnings (1Y)-223.95%
FCF Growth (3Y)62.18%
Quality
Return on Equity
-0.69%
ROIC-0.20%
Net Margin-1.19%
Op. Margin-0.49%
Safety
Debt / Equity
0.10
Current Ratio2.39
Interest Coverage-0.21
Valuation
P/E Ratio
-95.12
Forward P/EN/A
P/B Ratio0.67
EV/EBITDAN/A
Dividend Yield0.00%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | 21.12% | Revenue Growth (3Y) | 17.06% |
| Earnings Growth (1Y) | -223.95% | Earnings Growth (3Y) | N/A |
| Revenue Growth (5Y) | 16.58% | Earnings Growth (5Y) | N/A |
| Profitability | |||
| Revenue (TTM) | 449.72M | Net Income (TTM) | -5.37M |
| ROE | -0.69% | ROA | -0.51% |
| Gross Margin | 33.49% | Operating Margin | -0.49% |
| Net Margin | -1.19% | Free Cash Flow (TTM) | 68.34M |
| ROIC | -0.20% | FCF Growth (3Y) | 62.18% |
| Safety | |||
| Debt / Equity | 0.10 | Current Ratio | 2.39 |
| Interest Coverage | -0.21 | ||
| Dividends | |||
| Dividend Yield | 0.00% | Payout Ratio | 0.00% |
| Dividend Growth (3Y) | N/A | Dividend Growth (5Y) | N/A |
| Consecutive Div Years | N/A | ||
| Valuation | |||
| P/E Ratio | -95.12 | Forward P/E | N/A |
| P/B Ratio | 0.67 | P/S Ratio | 1.14 |
| PEG Ratio | 0.50 | Forward PEG | N/A |
| EV/EBITDA | N/A | Fwd EV/EBITDA | N/A |
| Forward P/S | N/A | Fwd Earnings Yield | N/A |
| FCF Yield | 13.38% | ||
| Market Cap | 510.76M | Enterprise Value | 512.22M |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 449.72M | 371.30M | 328.20M | 293.56M | 243.48M |
| Net Income | -5.37M | 4.33M | -16.84M | -29.89M | 15.68M |
| EPS (Diluted) | -0.05 | 0.04 | -0.16 | -0.26 | 0.13 |
| Gross Profit | 150.62M | 174.41M | 152.65M | 138.06M | 115.41M |
| Operating Income | -2.20M | 7.40M | -2.89M | -2.40M | -5.32M |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 1.05B | 963.80M | 945.49M | 1.05B | 991.89M |
| Total Liabilities | 278.80M | 168.69M | 198.62M | 228.98M | 149.87M |
| Shareholders' Equity | 766.65M | 795.11M | 746.87M | 825.86M | 842.02M |
| Total Debt | 77.85M | 49.46M | 69.09M | 77.70M | 40.96M |
| Cash & Equivalents | 76.39M | 80.11M | 58.76M | 71.68M | 85.96M |
| Current Assets | 394.51M | 396.81M | 365.12M | 395.62M | 307.32M |
| Current Liabilities | 165.13M | 111.25M | 114.03M | 141.32M | 105.30M |
Strategy Scores
This stock passed the criteria for 2 strategies
Score = fit strength (0–100)
Rank = position among all matches
#516 of 829
Custom
Full Throttle
#135 of 145
Recent Activity
Entered
Deep Value Investing (Seth Klarman)
Mar 27, 2026
Entered
Full Throttle
Mar 27, 2026